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Cyclin-dependent kinase 2 (Cdk2) is required for centrosome
duplication in mammalian cells
Yutaka Matsumoto*, Ken Hayashi† and Eisuke Nishida*
Centrosome duplication is indispensable for the
formation of the bipolar mitotic spindle. Surprisingly,
even if DNA replication or mitosis is inhibited,
centrosome duplication can still occur [1–5]. Thus, it
remains unknown how centrosome duplication is
coordinated with the cell cycle. Here, we show that
centrosome duplication requires cyclin-dependent
kinase 2 (Cdk2) in mammalian cells. We have found
that in Chinese hamster ovary (CHO) cells, whereas
centrosome duplication is not inhibited by hydroxyurea
(HU) treatment, which arrests the cells in S phase, it is
inhibited by mimosine treatment, which arrests the cells
in late G1 phase. Cdk2 activity was higher in HU-treated
cells than in mimosine-treated cells. Remarkably,
inhibition of the Cdk2 activity in HU-treated cells with
butyrolactone I or roscovitine [6], or by expression of
the Cdk inhibitor p21Waf1/Cip1, blocked the continued
centrosome duplication. Moreover, overexpression of
Cdk2 reversed the inhibition of centrosome duplication
by mimosine treatment. These results indicate a
requirement of Cdk2 activity for centrosome duplication
and therefore suggest an underlying mechanism for the
coordination of centrosome duplication with the cell cycle.
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Results and discussion
Centrosome duplication is known to repeat during the pro-
longed early S phase induced by treatment of CHO cells
with HU [4]. We first compared the effect of two cell cycle
inhibitors, mimosine and HU, on centrosome duplication
in CHO cells. Mimosine has been shown to inhibit the cell
cycle in late G1 phase [7]. Cells were arrested in quiescent
state (G0) and then induced to enter the cell cycle by the
addition of serum. Quiescent cells contained one centro-
some consisting of two centrioles (Figure 1a, 0 h). In the
presence of 2 mM HU, centrosome duplication is not
blocked. About 50–60% of cells treated with HU for
40 hours had more than two centrioles per cell (which were
clearly discernible), but about 30% of the cells had packed
centrioles, the number of which could not be counted
accurately. We therefore treated the cells with 0.5 µM
okadaic acid (OA) for 40 minutes to separate these packed
centrioles for accurate quantitation. After the OA treat-
ment, about 88% of the cells contained more than two cen-
trioles per cell (Figure 1b, HU 40 h). Using electron
microscopy, we verified that centrosome duplication
occurred without the OA treatment (see Supplementary
material published with this paper on the internet). 
The effect of mimosine on centrosome duplication was
different from that of HU. In the presence of 0.4 mM
mimosine, which inhibited S phase entry (data not shown),
only two centrioles were detected in more than 90% of the
cells even 40 hours after serum addition (Figure 1a,b).
Thus, no sign of centrosome duplication was observed in
the presence of mimosine. We confirmed this by using
electron microscopy (see Supplementary material). These
results may suggest that centrosome duplication is depen-
dent on some event occurring at the G1–S boundary.
Cdk2 is known to be activated as a Cdk2–cyclin E complex
at the G1–S boundary and as a Cdk2–cyclin A complex
during S phase progression [8]. We therefore examined
Cdk2 activity in CHO cells treated with mimosine or HU.
Lysates from cells treated with mimosine or HU were sub-
jected to an immunocomplex kinase assay for Cdk2 with
histone H1 as a substrate. In the presence of HU, Cdk2
activity increased significantly after the serum addition. In
the presence of mimosine, however, the increase in Cdk2
activity was significantly inhibited (Figure 1c). Both the
cyclin-E-associated H1 kinase activity and the cyclin-A-
associated H1 kinase activity were much lower in the pres-
ence of mimosine than in the presence of HU (Figure 1c).
Thus, mimosine, but not HU, arrests the cell cycle before
the rise in the activity of Cdk2, as suggested previously [9].
We therefore hypothesized that centrosome duplication
must depend on the activity of Cdk2.
To test this hypothesis, we examined whether inhibition
of Cdk2 activity suppresses the repeated centrosome
duplication in the presence of HU. To inhibit Cdk2 activ-
ity, we used two drugs, butyrolactone I and roscovitine,
both of which are reported to inhibit specifically the kinase
activity of Cdk2, Cdc2 or Cdk5 [6]. In a control experi-
ment in which dimethylsulfoxide (DMSO) was added (the
solvent for the drugs), about 77% of the cells contained
more than two centrioles per cell in the presence of HU.
In contrast, 85.7% of butyrolactone-I-incubated cells and
86.6% of roscovitine-incubated cells still had only two cen-
trioles per cell (Figure 2). Thus, both butyrolactone I and
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Figure 1
Centrosome duplication is inhibited by
mimosine treatment but not by HU treatment.
(a) CHO cells were serum starved (0.2% fetal
calf serum) for 48 h, split onto collagen-
coated glass coverslips at about 50%
confluency, then treated with 400 µM
mimosine (MIM) or 2 mM HU, together with
10% fetal calf serum, and incubated for 40 h.
The cells were treated with OA and stained
with anti-γ-tubulin antibody. Cells arrested in
the quiescent state (G0) are also shown (0 h).
The scale bar represents 10 µm. Magnified
images of the centrioles indicated by the
arrowheads and arrows are shown in the
upper and lower insets, respectively; here, the
bar represents 5 µm. (b) Quantification of the
number of centrioles per cell in the cells
treated with mimosine or HU for 0 h and 40 h.
More than 200 cells were counted in one
experiment and data are shown as the mean ±
standard deviation (error bars) of three
independent experiments. (c) Cdk2 activity in
the cells treated with mimosine or HU.
Lysates were obtained from mimosine-treated
or HU-treated cells (at 0 h, 20 h and 40 h) and
subjected to immunoprecipitation with 
anti-Cdk2 (IP: Cdk2), anti-cyclin E (IP: cyclin
E) or anti-cyclin A (IP: cyclin A) antibodies.
The immunoprecipitates were assayed for
kinase activity, and immunoprecipitates from
200 µg lysate protein were immunoblotted
with anti-Cdk2 antibody (IB: Cdk2). Total
lysates (50 µg protein) were immunoblotted
with anti-cyclin E (total cyclin E) or anti-cyclin
A (total cyclin A) antibodies.
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Figure 2
Butyrolactone I or roscovitine inhibits the
continued centrosome duplication in HU-
treated cells. (a) Cells were treated with HU
for 10 h and then an equal amount (7.2 µl per
2 ml medium) of DMSO, butyrolactone I stock
solution or roscovitine stock solution (the final
concentration of butyrolactone I or roscovitine
was 180 µM) was added. Cells were
incubated for a further 10–40 h and then the
drugs were removed before OA treatment and
staining with anti-γ-tubulin antibody. The bar
represents 10 µm. The centrioles indicated by
the numbered arrowheads are shown as
magnified images in the correspondingly
numbered insets; here, the bar represents
5 µm. (b) Quantification of the number of
centrioles per cell in the cells incubated with
DMSO, butyrolactone I or roscovitine in the
presence of HU. More than 200 cells were
counted in one experiment and data are
shown as the mean ± standard deviation of
three independent experiments.
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roscovitine strongly inhibited the continued centrosome
duplication in the presence of HU.
Next, we expressed the Cdk inhibitor p21Waf1/Cip1 (p21) in
HU-treated CHO cells to inhibit the activity of Cdk2. We
transfected a p21 expression plasmid or empty vector
together with a green fluorescent protein (GFP) expres-
sion plasmid as a transfection marker. By immunostaining
with anti-p21 antibody, we confirmed that p21 and GFP
were co-expressed (data not shown). Most of the cells
transfected with empty vector (about 89%), like non-trans-
fected cells, contained more than two centrioles per cell.
In contrast, the majority of the p21-expressing cells (about
68%) had only two centrioles per cell (Figure 3). Taken
together, these results indicate that Cdk2 activity is
required for centrosome duplication.
To test whether an increase in Cdk2 activity reverses the
inhibitory effect of mimosine treatment on centrosome
duplication, we overexpressed Cdk2 in mimosine-treated
cells. We transfected wild-type Cdk2 or kinase-dead Cdk2
(a single amino acid substitution of Thr160 for alanine)
[10] expression plasmids, or empty vector, together with
GFP plasmid. By immunostaining with anti-Cdk2 anti-
body, we confirmed that Cdk2 and GFP were co-
expressed (data not shown). The majority of the cells
transfected with either the empty vector or the kinase-
dead Cdk2 (about 77%) had only two centrioles per cell in
the presence of mimosine. In contrast, most of the cells
expressing wild-type Cdk2 (about 71.7%) contained more
than two centrioles per cell in the presence of mimosine
(Figure 4a,b). Using electron microscopy, we confirmed
that centrosome duplication actually occurred in the cells
expressing wild-type Cdk2. We identified GFP-express-
ing cells on CELLocates (Eppendorf) before fixation. In
four cells examined that expressed wild-type Cdk2, three
cells contained four centrioles per cell and one contained
three centrioles; these cells had normal triplet micro-
tubules (Figure 4c). Only two centrioles per cell were seen
in all the cells examined that had been transfected with
either empty vector or the kinase-dead Cdk2 plasmid
(Figure 4c). The H1 kinase activities of the immunopre-
cipitates obtained with anti-Cdk2, anti-cyclin E or anti-
cyclin A antibodies were significantly higher in the cells
expressing wild-type Cdk2 than in the cells transfected
with empty vector or the kinase-dead Cdk2 plasmid (see
Supplementary material). Thus, the increased H1 kinase
activity of Cdk2 seems to be associated with both cyclin E
and cyclin A. All these results clearly indicate that an
increase in Cdk2 activity is able to reverse the inhibition
of centrosome duplication induced by mimosine treat-
ment and therefore support our idea that Cdk2 activity is
required for centrosome duplication.
Our results strongly suggest that centrosome duplication 
is under the control of Cdk2. This enzyme has been 
previously shown to control DNA replication [8]. There-
fore, we propose that activation of Cdk2 is the mechanism
that ensures the concurrence of centrosome duplication
and DNA replication.  The continued centrosome duplica-
tion in the absence of DNA replication [1,4,5] is likely to be
due to the relatively high Cdk2 activity in the prolonged
S phase that occurs under these conditions. In the absence
of protein synthesis, cells cannot enter mitosis because of
the lack of mitotic cyclins, but centrosome duplication con-
tinues in the early embryos of the frog [3] and sea urchin
[2] though does not continue in somatic cells [11]. Oscilla-
tions in the activity of Cdk2 are independent of protein
Brief Communication 431
Figure 3
Expression of p21 inhibits the continued centrosome duplication in
HU-treated cells. (a) Empty vector or a p21 expression plasmid,
together with a GFP plasmid, were transfected into serum-starved
cells 24 h before the addition of serum. The cells were then treated
with 2 mM HU for 40 h and stained with anti-γ-tubulin antibody 
(γ-tubulin). Transfected cells were detected as those expressing GFP
(GFP). The bar represents 10 µm. The centrioles indicated by the
numbered arrowheads are shown as magnified images in the
correspondingly numbered insets; here, the bar represents 5 µm.
(b) Quantification of the number of centrioles per cell in the cells
transfected with empty vector and in those expressing p21. More than
200 cells were counted in one experiment and data are shown as the
mean ± standard deviation of three independent experiments.
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synthesis during the early embryonic cell cycles in Xenopus
[12]. In contrast, the formation of active Cdk2–cyclin E
complex in somatic cells requires de novo synthesis of
cyclin E [13]. Moreover, abnormal centrosome duplication
is a possible cause of the genomic instability frequently
seen in cancer cells [14,15]. Centrosome duplication is pos-
sibly restricted to one cycle by the proper control of Cdk2
activity. In conclusion, we have demonstrated the depen-
dence of centrosome duplication on the Cdk2 cell cycle
engine in mammalian cells. Therefore, our findings suggest
an underlying mechanism for the coordination of centro-
some duplication with the cell cycle. After submission of
this work, a paper appeared that reports a similar observa-
tion in Xenopus egg extracts [16].
Supplementary material
Additional methodological details and two figures showing transmis-
sion electron microscopy analysis of cells treated with mimosine or HU
and immunocomplex kinase assays of Cdk2-overexpressing cells are
published with this paper on the internet.
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Figure 4
Expression of Cdk2 reverses the inhibition of
centrosome duplication in mimosine-treated
cells. (a) Empty vector, or wild-type (WT) or
kinase-dead (KD) Cdk2 expression plasmids,
together with GFP plasmid, were transfected
into serum-starved cells 24 h before the
addition of serum. The cells were then treated
with 0.4 mM mimosine for 40 h and stained
with anti-γ-tubulin antibody (γ-tubulin).
Transfected cells were identified as those
expressing GFP (GFP). The bar represents
10 µm. The centrioles indicated by the
numbered arrowheads are shown as
magnified images in the correspondingly
numbered inset; here, the bar represents
5 µm. (b) Quantification of the number of
centrioles per cell in the cells transfected with
empty vector and in those expressing wild-
type Cdk2 or kinase-dead Cdk2. More than
200 cells were counted in one experiment
and data are shown as the mean ± standard
deviation of three independent experiments.
(c) Transmission electron microscopy analysis
of the cells transfected with empty vector and
those expressing wild-type Cdk2 or kinase-
dead Cdk2. The bar represents 400 nm.
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